AU2016902150A0 - Formulations and therapeutic uses thereof - Google Patents

Formulations and therapeutic uses thereof

Info

Publication number
AU2016902150A0
AU2016902150A0 AU2016902150A AU2016902150A AU2016902150A0 AU 2016902150 A0 AU2016902150 A0 AU 2016902150A0 AU 2016902150 A AU2016902150 A AU 2016902150A AU 2016902150 A AU2016902150 A AU 2016902150A AU 2016902150 A0 AU2016902150 A0 AU 2016902150A0
Authority
AU
Australia
Prior art keywords
formulations
therapeutic uses
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016902150A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indigo Ridge Pty Ltd
Original Assignee
Indigo Ridge Pty Ltd
Filing date
Publication date
Application filed by Indigo Ridge Pty Ltd filed Critical Indigo Ridge Pty Ltd
Publication of AU2016902150A0 publication Critical patent/AU2016902150A0/en
Priority to PCT/AU2017/050543 priority Critical patent/WO2017205939A1/en
Abandoned legal-status Critical Current

Links

AU2016902150A 2016-06-03 2016-06-03 Formulations and therapeutic uses thereof Abandoned AU2016902150A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2017/050543 WO2017205939A1 (en) 2016-06-03 2017-06-03 Vitamin d formulations and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
AU2016902150A0 true AU2016902150A0 (en) 2016-06-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP3720502A4 (en) Cytobiologics and therapeutic uses thereof
EP3324967A4 (en) Pridopidine base formulations and their use
EP3554558A4 (en) Hsp90-targeting conjugates and formulations thereof
EP3310376A4 (en) Modified therapeutic agents and compositions thereof
EP3434285A4 (en) Pharmaceutical composition and use thereof
ZA201904704B (en) Topical cyclosporine-containing formulations and uses thereof
EP3541385A4 (en) Pharmaceutical formulations
EP3307265A4 (en) Pharmaceutical combination and uses thereof
EP3534910A4 (en) Therapeutic agents and methods
EP3191114A4 (en) Occidiofungin formulations and uses thereof
EP3380525A4 (en) Pharmaceutical formulations and methods of use thereof
EP3638251A4 (en) Bisphosphocin gel formulations and uses thereof
EP3436467A4 (en) Novel compositions and therapeutic methods
EP3454847A4 (en) Improved drug formulations
EP3145549A4 (en) Topical formulations and uses thereof
EP3687501A4 (en) Iniparib formulations and uses thereof
EP3528787A4 (en) Pharmaceutical formulations and methods of making the same
EP3691629A4 (en) Nutrient-spore formulations and uses thereof
EP3142650A4 (en) Curcumin-peptide conjugates and formulations thereof
EP3353159A4 (en) Modified cytotoxins and their therapeutic use
EP3716766A4 (en) Benzoxaborole compounds and formulations thereof
EP3615502A4 (en) Therapeutic compounds and methods
EP3497080A4 (en) Pharmaceutical formulations and their use
EP3585355A4 (en) Topical formulations and methods
EP3302530A4 (en) Cdh26 based therapeutic agents and their use